Results of Annual General Meeting and General Meeting
14 juin 2023 08h30 HE
|
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Results of Annual General Meeting and General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a...
Ivy Brain Tumor Center Announces Interim Results of Two Clinical Trials Targeting High-Grade Glioma
02 juin 2023 15h50 HE
|
Ivy Brain Tumor Center
Phoenix, AZ, June 02, 2023 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute, the nation’s largest early-phase drug development program dedicated to brain cancer, is...
Brain Cancer Canada Grants Research Funds to Improve Survival Rates for Glioblastoma and Other Gliomas
25 mai 2023 11h00 HE
|
Brain Cancer Canada
TORONTO, May 25, 2023 (GLOBE NEWSWIRE) -- Brain Cancer Canada, a leading charity in the fight against brain cancer, is delighted to announce a $50,000 research grant to Dr. Amit Singnurkar at...
Brain Cancer Canada Awards CAD 50,000 Grant for Innovative Research to Improve Brain Cancer Diagnosis and Treatment
04 mai 2023 10h00 HE
|
Brain Cancer Canada
TORONTO, May 04, 2023 (GLOBE NEWSWIRE) -- Brain Cancer Canada is pleased to announce a $50,000 grant to support research on more effective diagnosis and treatment for adult brain cancer patients. ...
ITM, Helmholtz Munich and University Hospital Münster Announce Start of Phase I Clinical Trial with Radiotherapeutic ITM-31 for Glioblastoma
13 mars 2023 06h13 HE
|
ITM Isotope Technologies Munich SE
Garching/Munich, Munich and Münster, Germany, March 13, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, Helmholtz Munich and the Departments of...
The Voice Finalist Morgan Myles Joins the Glioblastoma Foundation® as a Celebrity Ambassador to Raise Awareness and Funding for Glioblastoma
22 févr. 2023 09h08 HE
|
Glioblastoma Foundation
DURHAM, N.C., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Morgan Myles was a top three finalist on the latest season of NBC's The Voice, and now she is hopeful to use her voice in a different way — to share...
The Voice Finalist Morgan Myles Joins the Glioblastoma Foundation® as a Celebrity Ambassador to Raise Awareness and Funding for Glioblastoma
22 févr. 2023 09h08 HE
|
Glioblastoma Foundation
DURHAM, N.C., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Morgan Myles was a top three finalist on the latest season of NBC's The Voice, and now she is hopeful to use her voice in a different way — to share...
FLAG Therapeutics Receives Rare Pediatric Disease (RPD) Designation for FLAG-003 for the Treatment of Children with Diffuse Intrinsic Pontine Glioma (DIPG)
31 janv. 2023 13h00 HE
|
Flag Therapeutics, Inc.
RALEIGH, N.C., Jan. 31, 2023 (GLOBE NEWSWIRE) -- FLAG Therapeutics, Inc., announced today that FLAG-003, an investigational small molecule therapy for the treatment of Diffuse Intrinsic Pontine...
Glioblastoma Multiforme Treatment Market Is Estimated to Grow at CAGR Of 8.1%, 2022-2029 | Latest Industry Coverage by Douglas Insights
11 janv. 2023 03h52 HE
|
Douglas Insights
Isle of Man, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Douglas Insights has added the Global Glioblastoma Multiforme treatment market research to its growing market reports. Douglas Insightsinsights tries...
Recent Advancements in Treatment will help Glioblastoma Treatment Drugs Market to Reach US$ 1.26 Bn at a CAGR of 5.7% Between Forecast Period of 2022-32 | Report by Future Market Insights, Inc.
07 nov. 2022 10h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The global glioblastoma treatment drugs market is worth US$ 723.3 Mn as of now and is expected to reach US$ 1.26 Bn by the year 2032 at a CAGR of 5.7%...